Global Pruritus Therapeutics Market Size, Status and Forecast 2020-2026
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
Skin disease is the fourth leading cause of nonfatal disease burden. Skin diseases include eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulcer, urticaria, scabies, fungal skin diseases, impetigo, abscess, and other bacterial skin diseases, cellulitis, viral warts, molluscum contagiosum, and non-melanoma skin cancer. Among these types, fungal skin diseases and pruritus were in the top 10 most prevalent diseases worldwide in 2010. Thus pruritus therapeutics market is growing with rising prevalence of skin diseases. Moreover, patent expiration of dermatitis drugs and the introduction of new products are also responsible for the growth of pruritus therapeutics market.
Market Analysis and Insights: Global Pruritus Therapeutics Market
In 2019, the global Pruritus Therapeutics market size was US$ 12520 million and it is expected to reach US$ 17690 million by the end of 2026, with a CAGR of 5.0% during 2021-2026.
Global Pruritus Therapeutics Scope and Market Size
Pruritus Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pruritus Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Pruritus Therapeutics market is segmented into Antihistamines, Corticosteroids, Calcineurin Inhibitors, Other, etc.
Segment by Application, the Pruritus Therapeutics market is segmented into External Use, Oral, Injection, etc.
Regional and Country-level Analysis
The Pruritus Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pruritus Therapeutics market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Pruritus Therapeutics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Pruritus Therapeutics business, the date to enter into the Pruritus Therapeutics market, Pruritus Therapeutics product introduction, recent developments, etc.
The major vendors include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma, GlaxoSmithKline, Galderma, Huapont, etc.
This report focuses on the global Pruritus Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pruritus Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Other
External Use
Oral
Injection
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Pruritus Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Pruritus Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Pruritus Therapeutics are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Skin disease is the fourth leading cause of nonfatal disease burden. Skin diseases include eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulcer, urticaria, scabies, fungal skin diseases, impetigo, abscess, and other bacterial skin diseases, cellulitis, viral warts, molluscum contagiosum, and non-melanoma skin cancer. Among these types, fungal skin diseases and pruritus were in the top 10 most prevalent diseases worldwide in 2010. Thus pruritus therapeutics market is growing with rising prevalence of skin diseases. Moreover, patent expiration of dermatitis drugs and the introduction of new products are also responsible for the growth of pruritus therapeutics market.
Market Analysis and Insights: Global Pruritus Therapeutics Market
In 2019, the global Pruritus Therapeutics market size was US$ 12520 million and it is expected to reach US$ 17690 million by the end of 2026, with a CAGR of 5.0% during 2021-2026.
Global Pruritus Therapeutics Scope and Market Size
Pruritus Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pruritus Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Pruritus Therapeutics market is segmented into Antihistamines, Corticosteroids, Calcineurin Inhibitors, Other, etc.
Segment by Application, the Pruritus Therapeutics market is segmented into External Use, Oral, Injection, etc.
Regional and Country-level Analysis
The Pruritus Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pruritus Therapeutics market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Pruritus Therapeutics Market Share AnalysisPruritus Therapeutics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Pruritus Therapeutics business, the date to enter into the Pruritus Therapeutics market, Pruritus Therapeutics product introduction, recent developments, etc.
The major vendors include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma, GlaxoSmithKline, Galderma, Huapont, etc.
This report focuses on the global Pruritus Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pruritus Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Market segment by Type, the product can be split into
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Other
Market segment by Application, split into
External Use
Oral
Injection
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Pruritus Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Pruritus Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Pruritus Therapeutics are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
